Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches
Marie Canton, Didier Le Gall, François Feillet, et al.
Journal of the International Neuropsychological Society (2019) Vol. 25, Iss. 6, pp. 624-643
Closed Access | Times Cited: 18

Showing 18 citing articles:

Meta-analyses of cognitive functions in early-treated adults with phenylketonuria
Cristina Romani, Andrew Olson, Lynne Aitkenhead, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104925-104925
Open Access | Times Cited: 28
The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: A systematic review and meta-analysis of the within-participant literature
Lucie Thomas, Andrew Olson, Cristina Romani
Molecular Genetics and Metabolism (2022) Vol. 138, Iss. 1, pp. 106969-106969
Open Access | Times Cited: 19
Psychosocial Challenges Facing Young People With Inherited Metabolic Disorders and Their Parents: A Systematic Review
Clara Sherlock, Kim Clarke, Norah Jordan
JIMD Reports (2025) Vol. 66, Iss. 2
Open Access
Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry
Aileen Kenneson, Rani H. Singh
Molecular Genetics and Metabolism (2021) Vol. 134, Iss. 3, pp. 243-249
Open Access | Times Cited: 22
A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria
Hayley E. Clocksin, Emily E. Abbene, Shawn E. Christ
Journal of the International Neuropsychological Society (2022) Vol. 29, Iss. 7, pp. 641-650
Closed Access | Times Cited: 13
Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox
Shawn E. Christ, Hayley E. Clocksin, Maia Zalik, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 1, pp. 107579-107579
Closed Access | Times Cited: 8
Psychiatric Manifestations in Children and Adolescents with Inherited Metabolic Diseases
Valentina Baglioni, Fabiola Bozza, Giuliana Lentini, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2190-2190
Open Access | Times Cited: 2
La phénylcétonurie
Arnaud Wiedemann, Abderrahim Oussalah, Élise Jeannesson, et al.
médecine/sciences (2020) Vol. 36, Iss. 8-9, pp. 725-734
Open Access | Times Cited: 14
Executive functions in preschool-aged children with neurofibromatosis type 1: Value for early assessment
Marie-Laure Beaussart-Corbat, S. Barbarot, Denis Farges, et al.
Journal of Clinical and Experimental Neuropsychology (2021) Vol. 43, Iss. 2, pp. 163-175
Closed Access | Times Cited: 11
Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
Kimber van Vliet, Willem G. van Ginkel, Rianne Jahja, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 45, Iss. 5, pp. 952-962
Open Access | Times Cited: 8
Executive functions in preschool children with moderate hyperphenylalaninemia and phenylketonuria: a prospective study
Laetitia Paermentier, Aline Cano, B. Chabrol, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Occurrence of Inborn Errors of Metabolism in Newborns, Diagnosis and Prophylaxis
Alok Bharadwaj, Nitin Wahi, Aditya Saxena
Endocrine Metabolic & Immune Disorders - Drug Targets (2020) Vol. 21, Iss. 4, pp. 592-616
Closed Access | Times Cited: 8
Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients
Katia Irie Teruya, Eduardo Remor, Ida Vanessa Döederlein Schwartz
American Journal of Medical Genetics Part A (2021) Vol. 185, Iss. 7, pp. 1991-2002
Closed Access | Times Cited: 7
RETRACTED: Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study
Johannes Krämer
Molecular Genetics and Metabolism Reports (2020) Vol. 22, pp. 100573-100573
Open Access | Times Cited: 3
Neuropsychological Disorders in Moderate Hyperphenylalaninemia: Literature Review
Laetitia Paermentier, Ainara Cano, B. Chabrol, et al.
Developmental Neuropsychology (2023) Vol. 48, Iss. 1, pp. 31-45
Closed Access | Times Cited: 1
Hyperphenylalaninaemia
Peter Burgard, Robin Lachmann, John H. Walter
Springer eBooks (2022), pp. 337-354
Closed Access | Times Cited: 2
RETRACTED: Case-control study about the acceptance of Pegvaliase in Phenylketonuria
Johannes Krämer
Molecular Genetics and Metabolism Reports (2020) Vol. 22, pp. 100557-100557
Open Access
Psychopathological Risk Assessment in Children with Hyperphenylalaninemia
Maria Cristina Risoleo, Margherita Siciliano, Luigi Vetri, et al.
Children (2022) Vol. 9, Iss. 11, pp. 1679-1679
Open Access
Page 1

Scroll to top